These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Observations on leprosy among children born in the Culion Leper Colony during the pre-sulphone and the sulphone periods. LARA CB; IGNACIO JL J Philipp Med Assoc; 1956 Apr; 32(4):189-97. PubMed ID: 13346466 [No Abstract] [Full Text] [Related]
3. Treatment of sulphone resistant leprosy--a review of sixty one cases. Seshadri PS; Ravi NT Lepr India; 1982 Oct; 54(4):639-47. PubMed ID: 6191123 [No Abstract] [Full Text] [Related]
4. 4:4 diacetyl-diamino-diphenyl sulphone in the treatment of leprosy. Kundu S; Ghosh S Bull Calcutta Sch Trop Med; 1972 Apr; 20(2):30-1. PubMed ID: 4666676 [No Abstract] [Full Text] [Related]
5. The rate of relapse in lepromatous leprosy following completion of twenty years of supervised sulphone therapy. Waters MF; Rees RJ; Laing AB; Khoo Kah Fah ; Meade TW; Parikshak N; North WR Lepr Rev; 1986 Jun; 57(2):101-9. PubMed ID: 3747702 [No Abstract] [Full Text] [Related]
6. Maintenance of leprosy endemicity and bacterial positivity of lepromatous patients under treatment with sulfones. Bechelli LM; Dominguez VM Int J Lepr Other Mycobact Dis; 1971; 39(2):461. PubMed ID: 5169809 [No Abstract] [Full Text] [Related]
7. The pharmacology of sulphetrone and its implications in sulphone resistance. Gelber RH; Gooi HC; Waters MF; Rees RJ Lepr Rev; 1974 Dec; 45(4):308-12. PubMed ID: 4444392 [No Abstract] [Full Text] [Related]
11. [Significance of leprosy in the Central European region]. Hermans EH Internist (Berl); 1966 Dec; 7(12):602 passim. PubMed ID: 4870024 [No Abstract] [Full Text] [Related]
12. The treatment of leprosy with the sulfones. I. Faget's original 22 patients. A thirty-year follow-up on sulfone therapy for leprosy. Jacobson RR; Trautman JR Int J Lepr Other Mycobact Dis; 1971; 39(3):726-37. PubMed ID: 4948221 [No Abstract] [Full Text] [Related]
13. Controlling the spread of leprosy--some observations on. Dharmendra Lepr India; 1976 Jul; 48(3):217-30. PubMed ID: 66418 [No Abstract] [Full Text] [Related]
14. Studies on sulfone resistance in leprosy. I. Detection of cases. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069 [No Abstract] [Full Text] [Related]
15. Treatment of leprosy with diaminodiphenyl sulphone (DDS). MUIR E Trans R Soc Trop Med Hyg; 1952 Mar; 46(2):113-22. PubMed ID: 14922479 [No Abstract] [Full Text] [Related]
16. Sulfone resistance and leprosy control. Lechat MF Int J Lepr Other Mycobact Dis; 1978; 46(1):65-7. PubMed ID: 565757 [No Abstract] [Full Text] [Related]
17. Studies on sulfone resistance in leprosy. 2. Treatment with a riminophenazine derivative (B.663). Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1966; 34(4):391-7. PubMed ID: 6006070 [No Abstract] [Full Text] [Related]
18. [Remarks on the epidemiology of leprosy in France in the past 50 years]. Basset A Bull Mem Acad R Med Belg; 1984; 139(2):156-64. PubMed ID: 6386078 [No Abstract] [Full Text] [Related]
19. [Leprosy in Tunisia]. Barta T Cesk Otolaryngol; 1972 Feb; 21(1):33-7. PubMed ID: 5010378 [No Abstract] [Full Text] [Related]
20. A 20-year study of the leprosy control programme at the Government Leprosy Treatment and Study Centre at Tirukoilur in south India. Radhakrishna S; Christian M; Nair NG Indian J Med Res; 1982 Jul; 76():18-35. PubMed ID: 7174008 [No Abstract] [Full Text] [Related] [Next] [New Search]